Skip to main content

Paroxysmal Supraventricular Tachycardia

PSVT Clinical Trials for a Healthy Heart

Are You Experiencing Episodes Of Rapid Heartbeats?

If you suffer from PSVT episodes and are interested in using a study drug, you may qualify for the PSVT study.

PSVT (Paroxysmal Supraventricular Tachycardia) affects approximately 2 million Americans. Some of the most commonly reported symptoms include rapid heartbeats, sweating, chest pressure or pain, shortness of breath, tiredness, and anxiety.
We’re investigating a study drug (portable nasal spray) that may be able to help stop a PSVT episode.

You may be able to qualify for the PSVT study if you:

  • Are 18 years or older
  • Have been diagnosed with PSVT

*Other criteria may apply 

Prime Revival Research Institute is conducting clinical research trials on a potential PSVT treatment i.e. nasal spray, to observe its safety and efficacy when administered to people suffering from PSVT. The purpose of the PSVT study is to determine whether the investigational drug is effective in stopping a PSVT episode.

*Participation in the PSVT clinical trial is free of cost to both you and your insurance. To see if you qualify for the study, please fill the form. Someone from our research staff will give you a phone call and they might ask you questions about your medical history and information about any medications you take. 

**If you qualify and decide to participate, you will receive study-related care from experienced healthcare professionals including Cardiologists and nurses. 

Please provide YOUR contact information only.
Sign Up for PSVT Clinical Trials

About the PSVT Study

The PSVT study is looking at alternative treatment options available for people suffering from PSVT episodes. The potential Paroxysmal Supraventricular Tachycardia treatment is a nasal spray that is designed to quickly end a PSVT episode. The study medication has been designed to be used by patients to treat themselves whenever they suffer from an episode of PSVT.

Participants may pre-qualify for the PSVT clinical trial if they:

  • Are 18 years or older
  • Have been diagnosed with PSVT
  • Can easily use the study treatment

Pre-qualified patients will undergo a screening process that might include a phone call and a visit to one of our sites that is within a 50-mile radius. If you qualify and decide to participate in the research study, you will receive close monitoring and care from a healthcare team experienced in clinical studies. Participation in the PSVT research study is free of cost to you and no insurance is required.

About Paroxysmal Supraventricular Tachycardia

PSVT causes rapid and spontaneous heartbeats from time to time due to abnormalities in the electrical pathways of the heart. PSVT is common in younger people, especially women. The most obvious symptom of this condition is a faster pulse for no clear reason. Other symptoms include breathlessness, general tiredness, dizziness, chest tightness, and fainting. Often times people suffering from a Paroxysmal Supraventricular Tachycardia episode may visit the emergency room to receive treatment. However, some of the other paroxysmal supraventricular tachycardia treatment options may include daily medications, or cardiac ablation (an invasive surgical procedure that may fix the abnormal electrical signals in the heart).

Paroxysmal Supraventricular Tachycardia

Not RecruitingSTATUS AND CRITERIA

$ 99

Per Month
  • Age 18 Years and Above
  • Gender Male and Female
  • Condition Paroxysmal Supraventricular Tachycardia
  • Location Texas
Enroll Now

What to Expect?

If you qualify for the Paroxysmal Supraventricular Tachycardia study, you might be assigned to a group where you either receive the placebo (medication without the active ingredient) or the study drug. The study team will not know which medication you receive as this is a double-blind, placebo-controlled study.

More details about the research study will be provided to participants once they qualify for the screening process. If you decide to participate, the study doctor will go through the study criteria and the length of your participation in the Informed Consent Process.

We encourage all participants to ask as many questions as they’d like before deciding to participate in a research study. Participants receive complete study-related care, free of cost from healthcare professionals and, insurance is not required to participate.

FAQs

1. Is PSVT life-threatening?

PSVT is not life-threatening but in the presence of other underlying heart-related conditions, it could increase the risk of heart failure, abnormal heart rhythms, and heart pain which could eventually lead to a heart attack.

2. Are there any risks associated with participating in the PSVT study?

Every clinical trial has some risks associated with it. The PSVT study is no exception to this. You might experience some side effects from the study drug. If you decide to participate and experience any side effects from the study drug, you should immediately report to your study doctor or someone from the study team.

3. What is an investigational drug?

An investigational drug, also known as an experimental drug, is a pharmaceutical product that is studied to assess safety, dosage, and efficacy in humans to treat medical diseases.

4. Can I leave the study once it has started?

Your participation in the clinical trial is completely voluntary. If you think you’d like to stop participating in the study, please inform the study doctor. If you decide to leave the study early, you might be invited onto the site for a final visit so that the study doctor could ensure your health and safety.